Skip to content

Single Center Randomized Pilot Study Of Colorectal Cancer Screening Outreach

Single Center Randomized Pilot Study Of Colorectal Cancer Screening Outreach

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02594150
Acronym
CRCSO
Enrollment
897
Registered
2015-11-02
Start date
2015-12-31
Completion date
2018-09-30
Last updated
2019-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Brief summary

A four arm randomized pilot study to assess if the rate of completion of Fecal Immunochemical Test is increased by the addition of financial incentives.

Detailed description

This is a single center 4-arm randomized pilot study to assess if the rate of completion of Fecal Immunochemical Test (FIT) is increased by the addition of financial incentives. Potentially eligible subjects will be identified via a data abstraction by Penn Data Store. We will conduct Electronic Medical Record (EMR) reviews on randomly select patients from the data abstraction using PennChart to confirm eligibility until 1,080 patients are identified. We will then randomize these 1,080 patients to one of four arms during the intervention phase. * Arm 1: mailed FIT kit (usual care) * Arm 2: mailed FIT kit + a gift card included in mailing (unconditional fixed incentive) * Arm 3: mailed FIT kit + guarantee of receiving a gift card if kit is returned within two months (conditional fixed incentive) * Arm 4: mailed FIT kit + entry in a 1/10 chance lottery to receive a gift card if kit is returned within two months (conditional lottery incentive) All 1,080 subjects will receive the mailed FIT kit. Subjects whose FIT results are not recorded in PennChart will receive a follow-up phone call via Interactive Voice Response (IVR) three weeks after the kit was mailed to the subject. Subjects whose FIT results are not recorded in PennChart will receive a follow-up mailed reminder six weeks after the kit was mailed to the subject. Subjects will receive follow-up regardless of the arm to which they are randomized. A random sub-sample of 200 subjects will be called at least twelve weeks after the kit was mailed to the subject to complete a questionnaire. Verbal consent will be obtained from this sub-sample. This phone call will occur after the intervention and follow-up phases are completed. Analysis will occur after the sub-sample questionnaire phase is completed.

Interventions

OTHERFinancial Incentive

Financial incentives provide small immediate and tangible rewards that are aligned with the abstract long-term rewards of cancer prevention.

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
50 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Between 50 to 75 years old * Has had at least two visits at Penn Family Care Within the past two years - Due for screening * Asymptomatic for colorectal cancer (CRC) * Zip code listed in PennChart as part of the subjects address is within the Philadelphia-Wilmington-Camden Metropolitan Statistical Area * Have a primary care provider in Penn Family Care

Exclusion criteria

* Has had prior colonoscopy within 10 years, sigmoidoscopy within 5 years, and fecal occult blood test (FOBT)/FIT within twelve months of the chart review (We will exclude patients who self-report undergoing any of the above procedures) * Has a history of CRC * Has a history of other GI cancer * Has history of confirmed Inflammatory Bowel Disease (IBD) (e.g. Crohn's disease, ulcerative colitis; Irritable bowel syndrome does not exclude patients) * Has history of colitis other than Crohn's disease or ulcerative colitis * Has had a colectomy * Has a relative that has been diagnosed with CRC * Has been diagnosed with Lynch Syndrome (i.e. HNPCC) * Has been diagnosed with Familial Adenomatous Polyposis (FAP) * Has anemia (iron-deficient or general/unspecified) * Has history of lower GI bleeding * Has metastatic (Stage IV) blood or solid tumor cancer * Has end stage renal disease * Has had congestive heart failure * Has dementia * Has cirrhosis or end stage liver disease * Has any other condition that, in the opinion of the investigator, excludes the patient from participating in this study

Design outcomes

Primary

MeasureTime frameDescription
Increase in return rate of completed FIT2 monthsAn increase in return rate of completed FIT between intervention arms when compared to the control arm

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026